Your browser doesn't support javascript.
loading
Small molecule inhibitors of IκB kinase ß: A chip-based screening and molecular docking simulation.
Cho, Yong Wan; Lim, Hye Jin; Han, Moon Hi; Kim, Byung-Chul; Han, Sanghwa.
Afiliação
  • Cho YW; Department of Biochemistry, Kangwon National University, Chuncheon 24341, Republic of Korea; Proteogen Inc., Seoul, Republic of Korea; Shebah Biotech Inc., G-Tech Village, Chuncheon, Republic of Korea.
  • Lim HJ; Proteogen Inc., Seoul, Republic of Korea.
  • Han MH; Proteogen Inc., Seoul, Republic of Korea.
  • Kim BC; Department of Biochemistry, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Han S; Department of Biochemistry, Kangwon National University, Chuncheon 24341, Republic of Korea. Electronic address: hansh@kangwon.ac.kr.
Bioorg Med Chem ; 28(9): 115440, 2020 05 01.
Article em En | MEDLINE | ID: mdl-32205046
ABSTRACT
A chip-based screening system for IκB kinase ß (IKKß) has been developed by physically immobilizing the substrate IκBα on a glass matrix using a calixarene linker. Phosphorylation of IκBα by IKKß and ATP was quantitated using a fluorescently labeled antibody. Using this efficient assay system a chemical library of 2000 bioactive compounds was screened against IKKß and four were identified as good inhibitors, namely, aurintricarboxylic acid, diosmin, ellagic acid, and hematein. None of them have been reported to be an inhibitor of IKKß although they were implicated in various NFκB-mediated biological processes. Our enzyme-based assay showed that IC50 of the four inhibitors is comparable with that of IKK-16, a previously known strong inhibitor. Molecular docking simulation shows that the hydrophobic moiety of an inhibitor interacts with the four hydrophobic residues (Leu21, Val29, Val152, and Ile165) of the active site. The MM-PBSA calculation suggests that these hydrophobic interactions appear to be the predominant contributor to the binding free energy. As IKKß is ubiquitously expressed in various cell types and executes many biological functions, the enzyme and cell specificity of the four inhibitors need to be rigorously tested before accepted as a drug candidate.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Quinase I-kappa B / Bibliotecas de Moléculas Pequenas / Simulação de Acoplamento Molecular Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Quinase I-kappa B / Bibliotecas de Moléculas Pequenas / Simulação de Acoplamento Molecular Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article